On March 10, 2015, the U.S. Food and Drug Administration (FDA) approved dinutuximab (Unituxin) for the treatment of pediatric patients with high-risk neuroblastoma
FDA Approves First Immunotherapy for Children With Cancer
FDA Approves First Immunotherapy for Children With Cancer
#cancer #cancer in children #neuroblastoma #pediatrics